MTND5P22

Across TCGA pan-cancer cohorts, MTND5P22 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MTND5P22 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher MTND5P22 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND5P22 expression acts as an unfavorable survival marker.

COAD, THCA, and LUAD are the cancer types where MTND5P22 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.142	0.871	<.001	72	view →
THCA	OS	Tertile	All	0.586	0.942	<.001	63	view →
LUAD	OS	Tertile	All	0.235	0.697	.010	36	view →
BLCA	OS	Tertile	IV	0.130	0.599	.002	36	view →
PAAD	OS	Tertile	All	0.270	0.618	.011	36	view →
LGG	DFS	Tertile	All	0.337	0.742	.001	30	view →
KIRC	DFS	Tertile	IV	0.332	0.625	.030	24	view →
GBM	OS	Tertile	All	0.170	0.418	.031	18	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	18	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MTND5P22–COAD (OS)

Open the COAD breakdown →